These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6002407)

  • 1. [Clinical contribution the the therapy of multiple myeloma with phenylalanine mustard (melphalan)].
    Giardin A; Del Mela P; Morandi GA
    Riv Crit Clin Med; 1966 Aug; 66(3):244-54. PubMed ID: 6002407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience on the use of l-phenylalanin nitrogen mustard (melphalan)].
    Artigas L; Dondo Lascano F; Seoane MR; Sagasta C
    Prensa Med Argent; 1970 Mar; 57(3):142-8. PubMed ID: 4989273
    [No Abstract]   [Full Text] [Related]  

  • 3. [Three cases of multiple myeloma and clinical application of melphalan treatment].
    Fukuhara M; Tsujii T; Fukuda S; Matsumori T; Fukui S
    Rinsho Ketsueki; 1972 Aug; 13(4):582-8. PubMed ID: 4674852
    [No Abstract]   [Full Text] [Related]  

  • 4. [Melphalan in multiple myeloma].
    Ben-Bassat Y
    Harefuah; 1971 Feb; 80(3):141-3. PubMed ID: 5099255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)].
    Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA
    Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythroleukemia following melphalan therapy for multiple myeloma.
    Fishman SA; Ritz ND
    N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of multiple myeloma with melphalan].
    de Halleux F
    Presse Med (1893); 1967 Nov; 75(46):2307-10. PubMed ID: 6054150
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma.
    Waller M; Moon JH; Irby R; Toone EC
    Clin Exp Immunol; 1971 Jan; 8(1):91-100. PubMed ID: 4993198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance therapy with low-dose of melphalan in multiple myeloma (author's transl)].
    Hirasawa Y; Nagaoka T; Kuto F; Tokuhiro H; Kikawada R
    Rinsho Ketsueki; 1980 Nov; 21(11):1646-54. PubMed ID: 7206225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Melphalan therapy in Myelomatosis].
    Ota H; Ikeda Y; Shibata T; Hattori H; Yasuma A
    Rinsho Ketsueki; 1972 Oct; 13(5):811-9. PubMed ID: 4674857
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple myeloma. A study of forty patients.
    Pick AI; Schonfeld J; Schreibman S; Frohlichman R; Pinkhas J
    Isr J Med Sci; 1974 Nov; 10(11):1371-8. PubMed ID: 4613698
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferative activity, response to therapy and survival in multiple myeloma.
    Riccardi A; Montecucco C; Merlini G; Ucci G; Cremonini N; Gobbi PG; Ascari E
    Haematologica; 1984; 69(2):148-62. PubMed ID: 6429002
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptichemio in multiple myeloma. (Preliminary results).
    Cavo M; Gobbi M; Tura S
    Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prolonged survival in a case of multiple myeloma treated with high dose of melphalan].
    Shibata T; Ikeda Y; Isobe T; Ota H; Nimi M
    Rinsho Ketsueki; 1973 May; 14(5):619-25. PubMed ID: 4738278
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy.
    Ota H; Ikeda Y; Shibata T; Hirabayashi N
    Nihon Ketsueki Gakkai Zasshi; 1974 Feb; 37(1):49-57. PubMed ID: 4526861
    [No Abstract]   [Full Text] [Related]  

  • 17. Melphalan and its role in the management of patients with multiple myeloma.
    Falco P; Bringhen S; Avonto I; Gay F; Morabito F; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):945-57. PubMed ID: 17627453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple myeloma (author's transl)].
    Nakatsuji T; Matsumoto N; Kaku K; Hiroshige Y; Oda S; Shinohara K; Yaga K; Fujii S; Miwa S; Kamei T; Nagasawa T; Tani S
    Rinsho Ketsueki; 1980 Mar; 21(3):347-55. PubMed ID: 7411874
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of myelomatosis with melphalan (author's transl)].
    Hasegawa M; Aoki M; Ogawa T; Imamura Y; Hino S
    Rinsho Ketsueki; 1977 Aug; 18(8):961-72. PubMed ID: 916219
    [No Abstract]   [Full Text] [Related]  

  • 20. Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation.
    Sharma A; Lokeshwar N; Raina V; Mohanti BK; Kumar R
    Natl Med J India; 2007; 20(3):121-4. PubMed ID: 17867615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.